| Patients in this study (n = 266) | |
---|---|---|
Male, n (%) | 212 | (79.7) |
Age, mean (SD) | 64.3 | (11.0) |
Clinical presentation, n (%) | ||
 STEMI | 95 | (35.7) |
 NSTE-ACS | 99 | (37.2) |
 Non-ACS | 72 | (27.1) |
Clinical outcomes at 30 days, n (%) | ||
 Deceased | 0 | (0) |
 New heart failure | 1 | (0.4) |
 New myocardial infarction | 0 | (0) |
 New stent thrombosis | 0 | (0) |
 New stroke | 0 | (0) |
 New bleeding event | 37 | (14.0) |
 Unplanned cardiac rehospitalisation | 3 | (1.1) |
PCI-specific PROM, mean (SD) | ||
 Overall score | 7.6 | (2.0) |